These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36712850)

  • 21. Comprehensive analysis of somatic mutator-derived and immune infiltrates related lncRNA signatures of genome instability reveals potential prognostic biomarkers involved in non-small cell lung cancer.
    Yang CZ; Yang T; Liu XT; He CF; Guo W; Liu S; Yao XH; Xiao X; Zeng WR; Lin LZ; Huang ZY
    Front Genet; 2022; 13():982030. PubMed ID: 36226174
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer.
    Liu J; Cui G; Ye J; Wang Y; Wang C; Bai J
    Front Cell Dev Biol; 2022; 10():753957. PubMed ID: 35433686
    [No Abstract]   [Full Text] [Related]  

  • 24. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma.
    Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S
    Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma.
    Gao C; Zhou G; Cheng M; Feng L; Cao P; Zhou G
    Front Genet; 2022; 13():956094. PubMed ID: 36330438
    [No Abstract]   [Full Text] [Related]  

  • 26. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer.
    Yin T; Zhao D; Yao S
    Front Genet; 2021; 12():679150. PubMed ID: 34163531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma.
    Zhou Y; Wang L; Zhang W; Ma J; Zhang Z; Yang M; Yu J; Luo J; Yan Z
    Dis Markers; 2022; 2022():6335155. PubMed ID: 35111268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
    Huang S; Zhang J; Lai X; Zhuang L; Wu J
    Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
    [No Abstract]   [Full Text] [Related]  

  • 30. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
    Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC
    World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma.
    Xia X; Zhang H; Xia P; Zhu Y; Liu J; Xu K; Yuan Y
    Front Oncol; 2021; 11():733595. PubMed ID: 34527595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression levels of lncRNAs are prognostic for hepatocellular carcinoma overall survival.
    Xue C; Zhao Y; Jiang J; Li L
    Am J Transl Res; 2020; 12(5):1873-1883. PubMed ID: 32509183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and immunological role of sulfatide-related lncRNAs in hepatocellular carcinoma.
    Huang XF; Fu LS; Cai QQ; Fan F
    Front Oncol; 2023; 13():1091132. PubMed ID: 36816914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.
    Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ
    Front Oncol; 2021; 11():738477. PubMed ID: 34568075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer.
    Chen E; Yi J; Jiang J; Zou Z; Mo Y; Ren Q; Lin Z; Lu Y; Zhang J; Liu J
    BMC Cancer; 2022 Oct; 22(1):1037. PubMed ID: 36195833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma.
    Geng W; Lv Z; Fan J; Xu J; Mao K; Yin Z; Qing W; Jin Y
    Front Cell Dev Biol; 2021; 9():657667. PubMed ID: 33855028
    [No Abstract]   [Full Text] [Related]  

  • 38. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.
    Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L
    Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976
    [No Abstract]   [Full Text] [Related]  

  • 39. A Genomic Instability-Related Long Noncoding RNA Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Lu J; Cao W; He Z; Wang H; Hao J; Xu J
    J Oncol; 2022; 2022():3090523. PubMed ID: 36072979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic instability-associated lncRNA signature predicts prognosis and distinct immune landscape in gastric cancer.
    Sun J; Jiang Q; Chen H; Zhang Q; Zhao J; Li H; Wang X; Fang Y; Ruan Y; Sun Y
    Ann Transl Med; 2021 Aug; 9(16):1326. PubMed ID: 34532463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.